BATM Advanced Communications (BVC) Competitors

GBX 18.92
-0.27 (-1.41%)
(As of 04/26/2024 ET)

BVC vs. SPEC, TSTL, DXRX, FARN, SCLP, CEL, KOO, EAH, FUM, and POLB

Should you be buying BATM Advanced Communications stock or one of its competitors? The main competitors of BATM Advanced Communications include INSPECS Group (SPEC), Tristel (TSTL), Diaceutics (DXRX), Faron Pharmaceuticals Oy (FARN), Scancell (SCLP), Celadon Pharmaceuticals (CEL), Kooth (KOO), ECO Animal Health Group (EAH), Futura Medical (FUM), and Poolbeg Pharma (POLB). These companies are all part of the "medical" sector.

BATM Advanced Communications vs.

BATM Advanced Communications (LON:BVC) and INSPECS Group (LON:SPEC) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, earnings, dividends, community ranking, analyst recommendations and profitability.

41.8% of BATM Advanced Communications shares are held by institutional investors. Comparatively, 67.2% of INSPECS Group shares are held by institutional investors. 26.2% of BATM Advanced Communications shares are held by company insiders. Comparatively, 25.6% of INSPECS Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

BATM Advanced Communications pays an annual dividend of GBX 1 per share and has a dividend yield of 5.3%. INSPECS Group pays an annual dividend of GBX 1 per share and has a dividend yield of 1.8%. INSPECS Group pays out -5,000.0% of its earnings in the form of a dividend.

In the previous week, INSPECS Group had 1 more articles in the media than BATM Advanced Communications. MarketBeat recorded 2 mentions for INSPECS Group and 1 mentions for BATM Advanced Communications. BATM Advanced Communications' average media sentiment score of 0.58 beat INSPECS Group's score of 0.34 indicating that BATM Advanced Communications is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BATM Advanced Communications
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
INSPECS Group
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

BATM Advanced Communications has higher earnings, but lower revenue than INSPECS Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BATM Advanced Communications£122.83M0.67£2.51MN/AN/A
INSPECS Group£202M0.29-£1.19M-£0.02-2,850.00

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BATM Advanced Communications
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
INSPECS Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

BATM Advanced Communications has a net margin of -0.16% compared to INSPECS Group's net margin of -0.59%. BATM Advanced Communications' return on equity of -0.17% beat INSPECS Group's return on equity.

Company Net Margins Return on Equity Return on Assets
BATM Advanced Communications-0.16% -0.17% 0.59%
INSPECS Group -0.59%-1.10%-0.03%

BATM Advanced Communications has a beta of 0.57, meaning that its stock price is 43% less volatile than the S&P 500. Comparatively, INSPECS Group has a beta of 2.26, meaning that its stock price is 126% more volatile than the S&P 500.

BATM Advanced Communications received 185 more outperform votes than INSPECS Group when rated by MarketBeat users. However, 100.00% of users gave INSPECS Group an outperform vote while only 49.48% of users gave BATM Advanced Communications an outperform vote.

CompanyUnderperformOutperform
BATM Advanced CommunicationsOutperform Votes
190
49.48%
Underperform Votes
194
50.52%
INSPECS GroupOutperform Votes
5
100.00%
Underperform Votes
No Votes

Summary

BATM Advanced Communications beats INSPECS Group on 10 of the 16 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BVC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BVC vs. The Competition

MetricBATM Advanced CommunicationsMedical Instruments & Supplies IndustryMedical SectorLON Exchange
Market Cap£82.55M£3.54B£4.96B£1.73B
Dividend Yield3.52%1.89%2.94%10.25%
P/E Ratio2,800.00334.24165.712,048.38
Price / Sales0.67139.032,378.19384,539.95
Price / Cash2.12124.7248.3926.37
Price / Book0.703.874.622.54
Net Income£2.51M£79.98M£103.91M£186.60M
7 Day Performance-1.43%0.48%0.74%1.62%
1 Month Performance-2.60%-6.26%-8.18%10.14%
1 Year Performance-25.78%-5.53%3.64%10.23%

BATM Advanced Communications Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SPEC
INSPECS Group
0 of 5 stars
GBX 52
-1.9%
N/A-42.4%£52.87M£202M-2,600.001,732
TSTL
Tristel
0.1237 of 5 stars
GBX 455
+2.2%
GBX 390
-14.3%
+46.6%£216.08M£39.49M3,500.00208
DXRX
Diaceutics
1.5122 of 5 stars
GBX 103
-0.5%
GBX 150
+45.6%
+3.6%£87.22M£21.90M10,500.00151
FARN
Faron Pharmaceuticals Oy
0 of 5 stars
GBX 127.50
+6.3%
N/A-60.3%£87.73M£-725,000.00-303.5734
SCLP
Scancell
0 of 5 stars
GBX 9.60
flat
N/A-39.0%£89.07M£5.27M-960.0051
CEL
Celadon Pharmaceuticals
0 of 5 stars
GBX 115
flat
GBX 222.50
+93.5%
-31.7%£73.84M£11,258.00-884.6224News Coverage
Gap Up
High Trading Volume
KOO
Kooth
1.262 of 5 stars
GBX 262
flat
GBX 580
+121.4%
+4.8%£95.58M£33.34M-9,033.33478News Coverage
EAH
ECO Animal Health Group
0 of 5 stars
GBX 94
flat
N/A-11.2%£63.68M£88.46M-4,700.00234News Coverage
FUM
Futura Medical
0 of 5 stars
GBX 35.55
-0.1%
N/A-27.9%£107.17M£1.70M-1,777.5012Gap Up
POLB
Poolbeg Pharma
0 of 5 stars
GBX 10.55
+3.4%
N/A+63.9%£52.75MN/A-1,055.0012

Related Companies and Tools

This page (LON:BVC) was last updated on 4/28/2024 by MarketBeat.com Staff

From Our Partners